KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Amgen (AMGN) over the last 16 years, with Q4 2025 value amounting to 0.14%.

  • Amgen's Return on Capital Employed rose 300.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.14% for FY2025, which is 400.0% up from last year.
  • Latest data reveals that Amgen reported Return on Capital Employed of 0.14% as of Q4 2025, which was up 300.0% from 0.13% recorded in Q3 2025.
  • In the past 5 years, Amgen's Return on Capital Employed registered a high of 0.2% during Q3 2022, and its lowest value of 0.09% during Q2 2024.
  • In the last 5 years, Amgen's Return on Capital Employed had a median value of 0.14% in 2023 and averaged 0.14%.
  • As far as peak fluctuations go, Amgen's Return on Capital Employed skyrocketed by 500bps in 2022, and later tumbled by -900bps in 2023.
  • Amgen's Return on Capital Employed (Quarter) stood at 0.15% in 2021, then skyrocketed by 31bps to 0.2% in 2022, then plummeted by -47bps to 0.1% in 2023, then grew by 2bps to 0.11% in 2024, then surged by 32bps to 0.14% in 2025.
  • Its Return on Capital Employed was 0.14% in Q4 2025, compared to 0.13% in Q3 2025 and 0.12% in Q2 2025.